What is XOMA Corporation's R&D?

XOMA Corporation (XOMA) reported R&D of $49K in Q1 2026.

How has XOMA Corporation's R&D changed year-over-year?

XOMA Corporation's R&D decreased by 96.2% year-over-year, from $1.29M to $49K.

What is the long-term trend for XOMA Corporation's R&D?

Over 4 years (2021 to 2025), XOMA Corporation's R&D has grown at a 77.9% compound annual growth rate (CAGR), from $171K to $1.71M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

XOMA Corporation XOMA R&D

R&D at other companies

Ligand PharmaceuticalsLGND

$2.15M-95.7%

Royalty PharmaRPRX

$39.79M-21.2%

Theravance BiopharmaTBPH

$5.83M-49.1%

Innoviva, Inc.INVA

$5.24M+19.2%

ZymeworksZYME

$34.46M-3.6%

Ultragenyx PharmaceuticalRARE

$187M+12.7%

Segments

By segment

See full

Single Reportable$49K-96.2%

Other financials

Income statement

See full

Revenue$12.3M-22.6%

Operating income-$480.0K-108%

Net income$4.5M+88.6%

EPS (diluted)$0.17+183%

Balance sheet

See full

Cash & equivalents$85.6M-5.2%

Total debt$124.7M+9.0%

Total equity$92.9M+9.7%

Total assets$271.9M+27.8%

Cash flow

See full

Operating cash flow$6.1M+178%

CapEx$3.0K-29.4%

Free cash flow-$2.9M+36.0%

Valuation

See full

Market cap$746.04M+159%

Enterprise value$785.17M+152%

P/E22.1×—

P/S15.4×+8.7×

Profitability

See full

Operating margin10.2%+5.5pp

Net margin69.6%+64.0pp

FCF margin-320%-118pp

Returns & leverage

See full

Return on equity38.1%+35.2pp

Debt / equity1.3×0.0×

Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is XOMA Corporation's R&D?: XOMA Corporation (XOMA) reported R&D of $49K in Q1 2026.
How has XOMA Corporation's R&D changed year-over-year?: XOMA Corporation's R&D decreased by 96.2% year-over-year, from $1.29M to $49K.
What is the long-term trend for XOMA Corporation's R&D?: Over 4 years (2021 to 2025), XOMA Corporation's R&D has grown at a 77.9% compound annual growth rate (CAGR), from $171K to $1.71M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.